ABEONA THERAPEUTICS INC. — Director's Dealing 2021

Sep 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABEONA THERAPEUTICS INC. (ABEO)
CIK: 0000318306
Period of Report: 2021-09-20

Reporting Person: O'Malley Brendan M. (SVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-20	Common stock	A	136000	—	Acquired	273454	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-20	Stock Option (right to buy)	$1.21	A	272000	Acquired	2031-09-20	Common Stock (272000)	Direct

Footnotes

F1: The restricted stock will vest 25% on each of September 20, 2022, September 20, 2023, September 20, 2024 and September 20, 2025.

F2: The options will vest 25% on September 20, 2022, and in 36 equal monthly installments thereafter.